BPC-157 is commonly described in research literature as a stable gastric pentadecapeptide and is studied in laboratory models involving gastric tissue, epithelial integrity, angiogenesis, tendon and ligament response, soft-tissue repair models, inflammation pathways and wound-healing research
Pray countersued, saying he was forced to resign after confronting Empower executives about problems with its ingredients
As well as concerns about the purity of the products, Taylor noted that peptides produced for research purposes could contain other ingredients that were dangerous for humans, or bacterial endotoxins
According to the method disclosed by the invention, two fragment peptides of solid-phase synthesis can be purified, so that impurities generated by racemization, oxidation and hydrolysis of a final semaglutide product are greatly reduced